510(k) Report

510(k) · Cleared

Cleared

Oridion Mac-Line Oral Nasal Cannula Sample Line

K012394510(k) SpecialCleared Aug 15, 200119-day reviewClass II21 CFR 868.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Oridion Medical 1987, Ltd. · CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase

Cleared on Aug 15, 2001 as substantially equivalent to K011050 (Oridion Medical 1987, Ltd., 2001) and 1 other predicate after a 19-day review. Its family tree reaches back 1 generation to 1987.

Decided
Aug 15, 2001
Review
19 days
Class
Class II
Product code
CCK
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K864199 (1987). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestorK864199 · Salter Labs #4001 Oral Nasal CO2 Sampling Cannula · Salter Labs · 19871985199019952000
Other ancestors, by generation 1 generation back: 1 other ancestor K864199 · Salter Labs #4001 Oral Nasal CO2 Sampling Cannula · Salter Labs · 19870
  1. Root · 1 generation backK864199 Salter Labs #4001 Oral Nasal CO2 Sampling CannulaSalter Labs · 1987
  2. This deviceK012394 Oridion Mac-Line Oral Nasal Cannula Sample LineOridion Medical 1987, Ltd. · 2001
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K864199Salter Labs #4001 Oral Nasal CO2 Sampling CannulaSalter Labs1987—
0 (this device)K012394Oridion Mac-Line Oral Nasal Cannula Sample LineOridion Medical 1987, Ltd.2001—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K012394, 1987–2001Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CCK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CCK device

  1. #1 K253030 Capnostream™35 Portable Respiratory Monitor…score 15.8 · 16 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011050Microstream Oral Nasal Cannula Filterline
Summary page 2
…'s exhalation. SUBSTANTIAL EQUIVALENCE: The Oridion MAC-Line Oral Nasal Cannula sample line is substantial equivalent to the Microstream Oral Nasal Cannula Filterline (K011050) and the Salter Labs Model 4001 Adult, Salter Labs Model 4101 Pediatric (FDA K864199), Oral Nasal Cannula, these devices legally…
Oridion Medical 1987, Ltd.20013
*K864199Salter Labs #4001 Oral Nasal CO2 Sampling Cannula
Summary page 2
…ple line is substantial equivalent to the Microstream Oral Nasal Cannula Filterline (K011050) and the Salter Labs Model 4001 Adult, Salter Labs Model 4101 Pediatric (FDA K864199), Oral Nasal Cannula, these devices legally marketed in the USA Oridion Medical 1987 Ltd. « POB 45025 - Jerusalem 91450 Israel…
Salter Labs1987—

Also cleared against K011050: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K011050.

How does its category compare?

All CCK devices

CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CCK

3in 2025

2007: 52008: 32009: 32010: 32011: 22012: 72013: 42014: 92015: 52016: 22017: 52018: 62019: 72020: 42021: 42022: 32023: 42024: 32025: 32026 (partial year): 3
2007high 9 (2014) · low 2 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CCK

169in 2025

2007: 56 days median2008: 248 days median2009: 101 days median2010: 125 days median2012: 150 days median2013: 132 days median2014: 166 days median2015: 105 days median2017: 134 days median2018: 296 days median2019: 261 days median2020: 188 days median2021: 227 days median2022: 226 days median2023: 555 days median2024: 592 days median2025: 169 days median2026 (partial year): 224 days median
2007high 592 (2024) · low 56 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CCK

1in 2022

2008: 12009: 192010: 42011: 142012: 32013: 2, 1 Class I2015: 12018: 52019: 7, 7 Class I2020: 12022: 1
2007high 19 (2009) · low 0 (2007)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · CCK

1,259in 2025

2007: 72008: 202009: 212010: 122011: 182012: 132013: 282014: 512015: 1142016: 882017: 582018: 632019: 1412020: 2,3022021: 2,2722022: 2,4752023: 1,6372024: 1,2162025: 1,259
2007high 2,475 (2022) · low 7 (2007)2025

MAUDE reports naming product code CCK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200755607
20083248120
200931011921
20103125412
20112—1418
20127150313
201341322 (1)28
20149166051
201551051114
20162—088
20175134058
20186296563
201972617 (7)141
2020418812,302
2021422702,272
2022322612,475
2023455501,637
2024359201,216
2025316901,259
202632240—

What is it indicated for?

The Oridion MAC-Line Oral Nasal Cannula sample line device is used whenever the physician needs to measure the CO, in a patient’s breathing in a non intubated patient.

The intended use of the Oridion MAC-Line Oral Nasal Cannula sample line is to conduct a sample of the patient’s breathing from the patient to the gas measurement device for measuring the percentage of COz in the patient's exhalation. The intended use of the modified device, as described in its labeling, has not changed as a result of the modification.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K012394: Oridion Mac-Line Oral Nasal Cannula Sample Line.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K012394

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026